Immunovant, Inc. (IMVT) Operating Lease, Liability USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Immunovant, Inc. quarterly Operating Lease, Liability history and growth rate from 2020 to 2024.
  • Immunovant, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $138 K, a 88.7% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $138 K -$1.08 M -88.7% Mar 31, 2024 10-K 2024-05-29
Q1 2023 $1.22 M -$1.14 M -48.4% Mar 31, 2023 10-K 2023-05-22
Q1 2022 $2.36 M -$1.05 M -30.8% Mar 31, 2022 10-K 2022-06-08
Q1 2021 $3.42 M -$783 K -18.6% Mar 31, 2021 10-K 2021-06-01
Q4 2020 $3.5 M Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $3.78 M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $4.2 M Jun 30, 2020 10-K 2021-06-01
Q1 2020 $4.2 M Apr 30, 2020 10-Q 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.